Theresa Goletz

Theresa Goletz has extensive experience in the biotechnology and pharmaceutical industry. Theresa is currently serving as the Vice President of Cancer Immunology & Immune Modulation at Boehringer Ingelheim since April 2023. Prior to this, they worked at GSK as the Global Head of Analytical Immunology & Cellular Platform from October 2021 to April 2023. Before joining GSK, Theresa ran their own consulting firm, Theresa Goletz Consulting, from 2015 to 2021 where they specialized in biotechnology and immunogenicity. Theresa also held leadership positions at EMD Serono, Inc. as the Global Head of NBE DMPK from January 2016 to February 2020, at Amgen as the Director of Medical Sciences and Clinical Immunology from December 2006 to December 2014, and at Centocor as a Principal Scientist from August 2000 to December 2006.

Theresa Goletz has a Bachelor of Arts (B.A.) degree in Biology, General from The College of Wooster. Theresa also holds a Doctor of Philosophy (Ph.D.) degree from Baylor College of Medicine.